Published: 05/10/2022 13:36 GMT Emergent Biosolutions Inc (EBS) - Emergent Hid Evidence of Quality Control Problems From FDA in Feb 2021, Six Weeks Before It Alerted Officials That 15 Million Doses Was Contaminated - Nyt.
Further Company Coverage: Ebsn ((reuters.
Briefs@thomsonreuters.
Com;)).
